Home/Human Life CORD/Nobutoshi Matsushita
NM

Nobutoshi Matsushita

Director

Human Life CORD

Human Life CORD Pipeline

DrugIndicationPhase
HLC-001Non-infectious pulmonary complications after hematopoietic stem cell transplantation (NIPCs)Phase 3
UndisclosedAutoimmune diseasesNon-clinical